The CDS platform (www.opencds.org) was used to implement algorithms based on the 2018 National Comprehensive Cancer Network guidelines for genetic evaluation of hereditary breast/ovarian and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback